"Letter to the editor submitted in response to “the extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin”." Journal of Dermatological Treatment, 29(1), pp. 105–106
Disclosure statement
No potential conflict of interest was reported by the authors.